Specialization
Pediatric hematology
Focus of research
Immunology of inhibitor development in mild and moderate hemophilia A
-
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study
the INSIGHT Study Group, Sept 2021, In: Journal of thrombosis and haemostasis. 19, 9, p. 2171-2181 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
The factor VIII treatment history of non-severe hemophilia A
Abdi, A., Kloosterman, F. R., Eckhardt, C. L., Male, C., Castaman, G., Fischer, K., Beckers, E. A. M., Kruip, M. J. H. A., Peerlinck, K., Mancuso, M. E., Santoro, C., Hay, C. R., Platokouki, H., van der Bom, J. G., Gouw, S. C., Fijnvandraat, K. & Hart, D. P., Dec 2020, In: Journal of thrombosis and haemostasis. 18, 12, p. 3203-3210 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Hemophilia management: Huge impact of a tiny difference: Huge impact of a tiny difference
Kloosterman, F., Zwagemaker, A.-F., Abdi, A., Gouw, S., Castaman, G. & Fijnvandraat, K., 1 Mar 2020, In: Research and practice in thrombosis and haemostasis. 4, 3, p. 377-385 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications